CytomX Therapeutics Data, Technology Stack, and Enterprise Applications
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2014 2014
Application Hosting and Computing Services IaaS 2021 2021
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2015 2015
Procurement
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Agiloft Legacy Agiloft Contract Lifecycle Management Contract Lifecycle Management Procurement n/a 2018 2018
CRM
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Customer Experience CRM 2019 2019
Customer Support CRM 2019 2019
Content Management
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Digital Signing Content Management 2021 2021
ERP Financial Management
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
ERP Financial ERP Financial Management 2014 2014
CyberSecurity
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Identity and Access Management (IAM) CyberSecurity 2021 2021
Secure Email Gateways (SEGs) CyberSecurity 2017 2017
IT Decision Makers and Key Stakeholders at CytomX Therapeutics
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by CytomX Therapeutics Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD CytomX Therapeutics Technographics

CytomX Therapeutics is a Life Sciences organization based in United States, with around 174 employees and annual revenues of $69.6 million.

CytomX Therapeutics operates a diverse technology stack with applications such as Microsoft Azure Cloud Services, Microsoft 365 and Agiloft Contract Lifecycle Management, covering areas like Application Hosting and Computing Services, Collaboration and Contract Lifecycle Management.

CytomX Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and Agiloft.

CytomX Therapeutics recently adopted applications including Google Cloud Platform (GCP) in 2021, DocuSign eSignature in 2021 and Okta Identity Cloud in 2021, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of CytomX Therapeutics’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates CytomX Therapeutics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete CytomX Therapeutics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.